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Abstract
Peripheral nerve regeneration following injury occurs spontaneously, but many of the processes 
require metabolic energy. The mechanism of energy supply to axons has not previously been 
determined. In the central nervous system, monocarboxylate transporter 1 (MCT1), expressed in 
oligodendroglia, is critical for supplying lactate or other energy metabolites to axons. In the 
current study, MCT1 is shown to localize within the peripheral nervous system to perineurial cells, 
dorsal root ganglion neurons, and Schwann cells by MCT1 immunofluorescence and MCT1 
tdTomato BAC reporter mice. To investigate whether MCT1 is necessary for peripheral nerve 
regeneration, sciatic nerves in MCT1 heterozygous null mice are crushed and peripheral nerve 
regeneration quantified electrophysiologically and anatomically. Compound muscle action 
potential (CMAP) recovery is delayed from a median of 21 days in wild-type mice to greater than 
38 days in MCT1 heterozygote null mice. In fact, half of the MCT1 heterozygote null mice have 
no recovery of CMAP at 42 days, while all of the wild-type mice recovered. In addition, muscle 
fibers remain 40% more atrophic and neuromuscular junctions 40% more denervated at 42 days 
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post-crush in the MCT1 heterozygote null mice than wild-type mice. The delay in nerve 
regeneration is not only in motor axons, as the number of regenerated axons in the sural sensory 
nerve of MCT1 heterozygote null mice at 4 weeks and tibial mixed sensory and motor nerve at 3 
weeks is also significantly reduced compared to wild-type mice. This delay in regeneration may be 
partly through failed Schwann cell function, as there is reduced early phagocytosis of myelin 
debris and remyelination of axon segments. These data for the first time demonstrate that MCT1 is 
critical for regeneration of both sensory and motor axons in mice following sciatic nerve crush.
Keywords
monocarboxylate transporter; metabolism; regeneration; peripheral nerve; nerve crush; perineurial 
cell; Schwann cell; dorsal root ganglion; axon; electron microscopy
INTRODUCTION
Peripheral nerve regeneration following injury occurs spontaneously in the peripheral 
nervous system (PNS) through an orchestrated series of events initiated by Wallerian 
degeneration. The cellular mechanisms of Wallerian degeneration involve multiple cell 
types, including Schwann cells, perineurial cells (also termed fibroblasts or glia), 
macrophages, and neurons (Zochodne 2012). These cells downregulate some genes, 
particularly those associated with synaptic transmission, while upregulating others, 
including those typically associated with development (Scherer, Wang et al. 1994; 
Parmantier, Lynn et al. 1999; Mueller, Leonhard et al. 2003; Hunt, Hossain-Ibrahim et al. 
2004; Gaudet, Popovich et al. 2011; Allodi, Udina et al. 2012; Blackmore 2012; Sulaiman 
and Gordon 2013). Many of these processes, including cell proliferation and gene activation, 
require metabolic energy. Despite this, little is known of the pathway for energy supply to 
peripheral nerves. Recent publications in the central nervous system (CNS) have suggested 
that monocarboxylate transporters (MCTs), particularly the oligodendroglial transporter 
MCT1 (SLC16A1), are critically important for supplying lactate to CNS axons 
(Funfschilling, Supplie et al. 2012; Lee, Morrison et al. 2012). In this study, we will 
investigate the dependence of peripheral nerves on MCT1 function.
Though originally thought to be a waste product of metabolism, evidence over the last few 
decades has established that lactate can be utilized as metabolic energy throughout the body 
(Gladden 2004). Intercellular lactate shuttles, in which a highly glycolytic cell produces 
lactate and transports it extracellularly through MCTs where it can be imported into adjacent 
cells that utilizes lactate for oxidative metabolism, have been found in muscle (Juel and 
Halestrap 1999) and the CNS (Pellerin, Pellegri et al. 1998; Magistretti and Pellerin 1999; 
Magistretti and Pellerin 2000; Funfschilling, Supplie et al. 2012; Lee, Morrison et al. 2012). 
MCTs are extracellular membrane channels that transport lactate, pyruvate and ketone 
bodies, along with protons, down their concentration gradient across membranes (Garcia, 
Goldstein et al. 1994). MCT1-4 have been shown to transport monocarboxylates (see 
(Pellerin, Bergersen et al. 2005) for review). Of these transporters, only MCT1 has thus far 
been localized to the peripheral nerve, being localized to the perineurium surrounding nerve 
fascicles (Takebe, Nio-Kobayashi et al. 2008).
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Perineurial cells, which form the layers of the perineurium (Du Plessis, Mouton et al. 1996), 
are connected by tight junctions and surrounded by basal lamina, thus making this layer 
restrictive to solutes from the blood and a primary component of the blood-nerve barrier 
(Akert, Sandri et al. 1976; Ghabriel, Jennings et al. 1989; Tserentsoodol, Shin et al. 1999). 
In addition to MCT1, perineurial cells also express the high-affinity glucose transporter, 
GLUT1, suggesting that perineurial cells may have an important metabolic function 
(Tserentsoodol, Shin et al. 1999; Takebe, Nio-Kobayashi et al. 2008). This metabolic role of 
perineurial cells may be particularly important in nerve growth, as recent studies from 
zebrafish have shown that these cells are necessary for peripheral nerve development and 
regeneration following injury (Kucenas, Takada et al. 2008; Binari, Lewis et al. 2013; Lewis 
and Kucenas 2014).
Direct evidence that peripheral nerves utilize lactate as metabolic energy in vivo is, thus far, 
lacking, but the dependence of axons on lactate has been conclusively demonstrated ex vivo 
in sciatic nerve explants (Brown, Evans et al. 2012). In this model system, application of 
glucose induces the production and release of lactate, and action potentials are reduced by 
blocking MCTs and subsequently restored by application of exogenous lactate. We postulate 
that peripheral nerves in vivo are also dependent on lactate, particularly during regeneration 
when they have their greatest requirement for energy. In this paper, we investigate the 
dependence of peripheral nerve regeneration on MCT1 by evaluating regrowth of sciatic 
nerve axons following nerve crush in MCT1 heterozygous null (MCT1 Het) mice.
METHODS
Animals
All mouse breeding and protocols were approved by the Johns Hopkins IACUC. Breeding 
colonies of MCT1 Het mice, obtained from Luc Pellerin and Pierre Magistretti, and BAC 
MCT1 tdTomato reporter mice (MCT1 Rep), previously described(Lee, Morrison et al. 
2012), were maintained at Johns Hopkins University. MCT1 Het and MCT1 Rep mice were 
both on a C57Bl6 background. Proteolipid protein (PLP) eGFP reporter mice (Mallon, Shick 
et al. 2002), provided by Dr. Dwight Bergles,, were on a B6/SJL mixed background.
Sciatic Nerve Crush
For nerve crush, 90–110 day old male transgenic (i.e., MCT1 Het null, BAC MCT1 
tdTomato reporter, or PLP-GFP reporter) or litter-mate wild-type mice were anesthetized 
with 2% isofluorane/oxygen, lateral thigh shaved, and a 1 cm incision in the skin made over 
the lateral femur, as published previously (Ma, Omura et al. 2011). The muscle layers were 
split with blunt scissors, the sciatic nerve localized and crushed with a ultra-fine, smooth, 
straight hemostat (tip width 0.6 mm/ Fine Science Tools) for 20 seconds. The skin incision 
was closed with surgical staples and animals allowed to recover on a warming blanket. At 
various time points following nerve crush, mice were anesthetized with chloral hydrate, 
perfused, either with saline or 4% paraformaldehyde, and dissected for dorsal root ganglia 
(DRG), spinal cord, sciatic nerve (both proximal and distal to crush zone), sural nerve, tibial 
nerve, and/or muscle. Mice were perfused with saline when isolating mRNA or protein to 
wash out red blood cells that express high amounts of MCT1 (Dubinsky and Racker 1978; 
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Garcia, Brown et al. 1995). The investigator performing the surgeries was blinded to the 
genotype of the mice.
Muscle histology and neuromuscular junction quantification
In one cohort of WT and MCT1 Het mice, mice were anesthetized by an overdose of chloral 
hydrate and sacrificed by cervical dislocation (without transcardial perfusion) 6 weeks 
following sciatic nerve crush. Gastrocnemius muscles ipsilateral and contralateral to sciatic 
nerve crush were dissected, weighed, and either partly embedded in tragacanth and quick 
frozen in dry-ice cooled 2-methylbutane (for muscle histology) or cryoprotected in 25% 
sucrose, stretched and frozen in O.C.T. Tissue Tek compound (Fisher; for neuromuscular 
junction (NMJ) staining). For histology, gastrocnemius muscle sections (20 μm) were cut 
transversely on a cryostat and processed with hematoxylin and eosin. For NMJ staining, 
gastrocnemius muscle sections (40 μm) were cut longitudinally onto slides with a cryostat, 
incubated with 4% paraformaldehyde for 20 minutes, washed in PBS, blocked in 5% normal 
goat serum (in PBS with 0.3% Triton-X) and then incubated in primary antibody to synapsin 
(1:1000; R and D systems) for 2 days at 4°C. Following washes with PBS, the slides were 
then incubated simultaneously with biotinylated anti-rabbit secondary antibody (1:200; 
Vector Laboratories) and tetramethyl rhodamine-conjugated α-bungarotoxin (1:50; Life 
Technologies) for two hours at room temperature. Finally, slides were washed in PBS, 
incubated in Streptavidin conjugated to Alexa-Fluor 488 (1:1000; Invitrogen) for 1 hour and 
coverslipped with Prolong Gold (Life Technologies). Quantification of NMJ staining 
(double-labelled or innervated post-synaptic NMJs versus total post-synaptic NMJs) was 
completed manually on a Nikon E800 fluorescence microscope by an investigator blinded to 
the animals’ genotype.
Electrophysiology
Prior to and 2 weeks following nerve crush, mice were evaluated for recovery of compound 
muscle action potentials (CMAPs) and conduction velocities biweekly through 6 weeks 
post-crush. These were completed by inserting stimulating electrodes in the sciatic notch in 
the vicinity of the proximal sciatic nerve, recording electrodes in the lateral plantar muscles 
of the foot pad, and a ground in the tail. All studies were completed with a Neurosoft-
Evidence 3102 electromyograph. The stimulation parameters were a current of 10mA, 
duration of 0.05ms, and frequency of 1 Hz, and were designed to provide maximal 
stimulation of sciatic nerve. The investigator conducting the electrophysiology was blinded 
to the genotype of the mice throughout the study.
MCT1 Antibody Production
MCT1 antibody was produced for the Rothstein laboratory by Aves Labs (Tigard). Using 
proprietary software, the company identified an appropriate antigen (amino acids 477-493 at 
the C-terminus of the mouse protein) and conjugated this peptide to KLH. The antigen-KLH 
complex was used to immunize two chickens, the serum affinity purified and antibody 
production verified by ELISA. We further validated the antibody by Western blots of brain 
and sciatic nerves from wild-type and MCT1 Het mice and HEK cells expressing 
recombinant MCT1 protein (Suppl. Fig. 1A). Specificity of primary antibody was confirmed 
by blocking experiments (negative control) and recombinant MCT1 protein (positive 
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control). For the blocking experiments in Western blots, the primary antibody was incubated 
overnight at 4°C with or without antigen peptide (MCT1 amino acids 477-493; 
concentration 5-fold primary antibody) prior to application to membrane. For the 
immunofluorescence blocking experiments, the primary antibody was incubated for 1 hour 
at room temperature with or without antigen peptide (5-fold primary antibody) prior to 
application to sections. The positive control was HEK cells transfected with a lentivirus 
expressing the full MCT1 protein. These HEK cells were lysed and homogenized in TPER 
prior to running 50 μg of protein on Western blot.
Real-time RT PCR and Western blots
In dissected DRG or nerve, MCT1 mRNA was isolated by RNeasy Mini Kit (Qiagen), 
reverse transcribed to cDNA with High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) and quantified by real-time RT PCR using Taqman probes (Applied 
Biosystems) for MCT1 relative to 18sRNA (DRG), actin, or peptidylprolyl isomerase A 
(PPIA; nerves) on a StepOne Plus RT-PCR System (Applied Biosystems). These 
housekeeping genes were chosen based on preliminary and/or published data (Girolami, 
Bouhy et al. 2010) that demonstrated gene expression to be stable following nerve crush. 
For Western blots, sciatic nerves, either proximal or distal to the crush, were homogenized 
in T-PER (Thermo Scientific) and run on Mini-Protean TGX Gels (10%; Bio-Rad) and 
transferred to nitrocellulose membranes (Bio-Rad). For all Western blots, 5 μg of sciatic 
nerves and 20 μg of brain were run on the gel. Membranes were incubated overnight with 
Rabbit polyclonal β-actin antibodies (AbCam; 1:3000) and visualized with Amersham ECL 
Reagant (GE Healthcare) on ImageQuant LAS 4000 (GE Healthcare). After visualizing β-
actin, blots were stripped with Restore Western Blot Stripping Buffer (Thermo Scientific), 
reprobed overnight with chicken antibodies specific for mouse MCT1 (Rothstein laboratory; 
1:300), and again visualized by ECL reagent, as described above.
Immunofluorescence and Electron Microscopy
Following transcardial perfusion with paraformaldehyde and dissection, as described above, 
tissue for immunofluorescence was post-fixed for 4 hours in 4% paraformaldehyde, 
cryoprotected in 20% sucrose and sectioned on a Leica CM1900 cryostat. Sections (20 μm 
thickness) were immunostained on slides for MCT1 (Rothstein lab; 1:500), S100 (Dako; 
1:500), MAC2 (CedarLane; 1:1000), claudin-1 (Novus Biologicals; 1:200), non-
phosphorylated or phosphorylated neurofilament (SMI32; Covance; 1:5000 or SMI31; 
Covance; 1:5000, respectively) either alone or in combination. Photomicrographs were 
taken on Zeiss LSM510 Meta confocal microscope. MAC2 immunofluorescent intensity 
was quantified by taking three randomly placed photomicrographs on the confocal 
microscope from each WT and MCT1 Het sciatic nerve post-crush, importing these images 
and quantifying in NIH Image J. For electron microscopy or semi-thin nerve histology, 
perfused nerves were post-fixed with 4% paraformaldehyde/2.5% glutaraldehyde for at least 
3 days and embedded in Epon 812 resin. Embedded nerves were cut either semi-thin (1 μm) 
and stained with toluidine blue or thin (70 nm) and stained with citrate/uranyl acetate. 
Toluidine blue stained nerves were used for quantification of myelinated axon number, 
myelin debris, or g-ratios. For each of these histologic features, photomicrographs of sural 
nerves were taken on Nikon E800, imported and quantified manually with Zeiss AxioVision 
Morrison et al. Page 5
Exp Neurol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
4.8 software. G-ratios were calculated as the ratio of the diameter of axons divided by the 
diameter of myelin sheaths. If more than one fascicle was present in sample, the largest 
nerve fascicle was quantified in its entirety. The researcher quantifying the nerves was 
blinded to transgene status. EM photomicrographs were produced on a Zeiss Libra 
transmission electron microscope.
Statistics
Student’s t-test was used to compare CMAP amplitudes (Figs. 2C, 3), axon number (Fig. 
2A), conduction velocity (Fig. 2D), and MAC2 immunofluorescence intensity (Fig. 7B). 
Log rank test was used to compare groups in time to recover compound motor action 
potentials (CMAPs; Fig. 3A). One-way ANOVA with Sidak’s multiple comparison tests 
was used to compare groups for MCT densitometry (Fig. 1C), CMAP amplitudes (Fig. 3C), 
muscle weights (Fig. 3G), neuromuscular junction (NMJ) innervation (Fig. 3H), G-ratios 
(Fig. 8C), and CMAP latencies (Fig. 8D). One-way ANOVA with Dunnett’s multiple 
comparison tests was used for MCT1 densitometry and mRNA (Figs. 4B,C, 5H). Two-way 
ANOVA with Bonferroni post-test was used to compare groups for myelinated axon number 
(Fig. 3C, D) and myelin debris over time (Fig. 8).
RESULTS AND DISCUSSION
MCT1 is highly expressed in the PNS within perineurial cells, Schwann cells and DRG 
neurons
MCT1 mRNA expression in the sciatic nerve is approximately 200-fold greater than 
expression of MCT2 or MCT4, which are the other MCTs demonstrated to transport lactate 
in the nervous system (Fig. 1A). This is similar to the expression in the CNS, described 
previously (Lee, Morrison et al. 2012). MCT1 Het mice, published previously (Lee, 
Morrison et al. 2012; Lengacher, Nehiri-Sitayeb et al. 2013), have, as expected, a partial loss 
of MCT1 mRNA (Fig. 1A) and protein (Fig. 1B,C) in the brain and sciatic nerve. Complete 
knockout of MCT1 is embryonically lethal and therefore could not be evaluated in this 
study. MCT1 Het mice, which display injury to CNS axons by 6 months of age (Lee, 
Morrison et al. 2012), were used to evaluate the function of MCT1 in the PNS. Western 
blots were completed with a novel MCT1 antibody that, as expected, confirms the 
approximately 50% reduction of MCT1 protein in both brain and sciatic nerves of MCT1 
Het mice (Fig. 1B,C). The specificity of the antibody is demonstrated by: 1) 50% reduction 
in Western blots of MCT1 Het mice (Fig. 1B,C; 2) selective immunostaining of a subset of 
myofibers, which are presumably type 1 myofibers based on prior publications, in the 
gastrocnemius muscle (Suppl. Fig. 1D)(McCullagh, Poole et al. 1996; Kobayashi 2004); 3) 
absence of immunoreactivity on Western blots or immunofluorescence of sciatic nerve after 
co-administration of antibody with blocking peptide (Suppl. Fig. 1A–F); and 4) specific 
labeling of MCT1 recombinant protein produced in HEK cells (Suppl. Fig. 1A; POS). By 
MCT1 immunofluorescence or the previously described MCT1 Rep mouse (Lee, Morrison 
et al. 2012), MCT1 in the sciatic nerve is strongly localized to perineurial cells (Fig. 1D–I; 
arrowheads). Perineurial cells also express Claudin-1 and co-localization with MCT1 Rep is 
found in the sciatic nerve (Fig. 1G–I). Though less intensely immunoreactive, Schwann 
cells, which are localized by S100 antibody, also co-localize MCT1 in the sciatic nerve (Fig. 
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1 J; arrows). The final cell type in the PNS that expresses MCT1, both in MCT1 Rep mice 
and WT mice immunostained with MCT1, is dorsal root ganglion (DRG) neurons (Fig. 1K, 
L). Though MCT1 appears to be expressed in peripheral nerve axons in MCT1 BAC mice 
(Fig. 1F), this may in fact be due to diffusion of tdTomato from DRG cell bodies into their 
axons, rather than true localization of the transporter within peripheral nerve axons. This is 
suggested by absence of co-localization of MCT1 immunoreactivity with phosphorylated 
neurofilaments, which label all sciatic nerve axons,in intact or crushed sciatic nerves (Suppl. 
Fig. 3A–D).
Using the MCT1 Rep mice and MCT1 immunofluorescence, our results confirm that MCT1 
is localized to perineurial cells within peripheral nerves, as described previously (Takebe, 
Nio-Kobayashi et al. 2008). MCT1 Rep mice provide a sensitive tool for studying cellular 
expression of a gene of interest, and generally recapitulate both the localization and relative 
level of mRNA expression. This makes them ideal tools for studying molecules expressed at 
low levels both during normal physiologic function and following injury or degeneration. 
Given that the BAC reporter reflects mRNA expression, not protein, and that antibodies can 
be limited by their specificity and sensitivity, other components of peripheral nerves, such as 
axons, may express small amounts of stable MCT1 protein below the level of detection for 
our BAC reporter mouse and immunofluorescence techniques.
Peripheral nerves in MCT1 Het mice are structurally and functionally intact
Uninjured peripheral nerves in MCT1 Het mice are no different morphologically or 
electrophysiologically than age-matched wild-type (WT) mice. Sural nerves from 90–110 
day old MCT1 Het mice, which is the age used for the subsequent experiments in this paper, 
show no evidence of axonal degeneration (Fig. 2). Axon number (Fig. 2A), axon diameter 
(Fig. 2B), and electrophysiologic characteristics, including compound muscle action 
potentials (CMAPs) and conduction velocity, in the sciatic nerve (Fig. 2C,D) are all 
unchanged compared to WT mice. Sural nerves from MCT1 Het mice demonstrate normal 
morphology by toluidine blue staining of semi-thin sections (Fig. 2J,K) and electron 
microscopy (Fig. 2L), compared to WT mice (Fig. 2G–I). Both myelinated and 
unmyelinated axons, localized to Remak bundles (Fig. 2I, L; arrows), are intact in MCT1 
Het mice (Murinson, Hoffman et al. 2005). Additionally, there are no appreciable 
abnormalities in the perineurium or extracellular space in MCT1 Het mice (Fig. 2E,F), 
despite the reduction in MCT1 expression.
The absence of axon degeneration in peripheral nerves of MCT1 Het mice is quite different 
from CNS axons in the same mice, which display axonal swellings throughout white and 
gray matter from an absence of MCT1 on oligodendrocytes (Nave 2010; Lee, Morrison et al. 
2012). The differences in susceptibility of PNS and CNS axons to reduced MCT1 
expression suggests that PNS axons are not as dependent on MCT1 supplied energy 
substrates (e.g., lactate, pyruvate, ketone bodies) under normal physiologic conditions as 
their CNS counterparts. Of course, complete reduction of PNS MCT1, which is not possible 
with these null mice due to embryonic lethality, may uncover some dependence of 
peripheral axons. Given the lack of degeneration in peripheral axons, we next aimed to 
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uncover a role for MCT1 in repair and injury responses by examining whether MCT1 is 
required for peripheral nerve regeneration.
Peripheral nerve regeneration is delayed in MCT1 Het mice following sciatic nerve crush
Despite showing no abnormalities in uninjured nerves, MCT1 Het mice have markedly 
delayed recovery of both motor and sensory axons following proximal sciatic nerve crush. 
Sciatic nerves were crushed in order to reliably injure all of the axons, while allowing 
efficient regeneration to appropriate target tissues. Following unilateral sciatic nerve crush, 
mice were allowed to recover for up to 6 weeks. The time to recover measureable (≥ 0.2 
mV) CMAPs (Fig. 3A; WT median 21 days, MCT1 Het median 38.5 days) and the average 
CMAP amplitude recovered over time (Fig. 3B) are significantly altered in MCT1 Het mice 
compared to WT mice. In addition to these electrophysiologic measures of motor nerve 
function, the number of regenerating myelinated axons from sural sensory and tibial mixed 
nerves, which are both distal to the crushed sciatic nerve, from MCT1 Het mice are also 
reduced (Fig. 3C–F). At 4 weeks following sciatic nerve crush in the sural nerve and 3 
weeks in the tibial nerve, the number of myelinated axons is significantly reduced, though 
they both recover by 6 weeks post-crush (Fig. 3C, D). Representative photomicrographs 
from WT (Fig. 3E) and MCT1 Het (Fig. 3F) sural nerves 4 weeks following sciatic nerve 
crush demonstrate the reduction in myelinated axons stained with toluidine blue. The 
electrophysiologic and pathologic alterations in peripheral nerve regeneration are 
accompanied by persistent atrophy (Fig. 3G, I–L) and failed reinnervation (Fig. 3H, M–P) of 
denervated MCT1 Het muscle. Gastrocnemius muscle weights from MCT1 Het mice 
ipsilateral (Denervated) to sciatic nerve crush at 6 weeks are reduced compared to either 
MCT1 Het contralateral (Non-denervated) or WT ipsilateral muscle (Fig. 3G). This is also 
reflected by muscle fiber atrophy in hematoxylin and eosin stained muscle cross-sections of 
denervated MCT1 Het gastrocnemius (Fig. 3L) compared to denervated WT (Fig. 3K) or 
non-denervated WT or MCT1 Het (Fig. 3I, J) gastrocnemius. The muscle atrophy in MCT1 
Het mice is due to persistent NMJ denervation at 6 weeks (Fig. 3H, P), a time point at which 
WT mice are fully re-innervated (Fig. 3H, O). WT muscle is fully re-innervated, despite 
incomplete recovery in CMAP amplitude by 6 weeks post-denervation. This is likely due to 
axonal sprouting of regenerated nerves at the muscle and enlarged motor units. Thus, by 
electrophysiology and pathology of nerves and muscles, MCT1 Het mice have a delay in 
both motor and sensory peripheral nerve regeneration. The delay in peripheral nerve 
regeneration following injury, but lack of abnormalities in uninjured peripheral nerves, 
suggests either that MCT1 is only important for peripheral nerves when energy need is 
highest, as during regeneration, or that there is a process specific to nerve regeneration that 
is dependent on MCT1. In order to begin evaluating the function of MCT1 in nerve 
regeneration, we evaluated MCT1 mRNA and protein expression in peripheral nerves and 
DRG by real-time RT PCR, Western blots, and MCT1 Rep mice.
Overall expression of MCT1 is reduced in peripheral nerves following sciatic nerve crush 
in WT mice
Intact and injured sciatic nerves from WT mice were isolated at 3, 7, and 14 days following 
sciatic nerve crush. Sciatic nerves were dissected into segments proximal or distal to the 
crush site and proteins isolated, while sciatic nerve segments from a second cohort of mice 
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proximal to the nerve crush, at the crush site, or distal to the crush were dissected and 
processed for mRNA. Expression of both MCT1 protein (Fig. 4A, B; Western blots) and 
mRNA (Fig. 4C; real-time RT PCR) are initially reduced in all nerve segments at 3 days 
post-crush relative to uncrushed nerves (***, p<0.001; * p<0.05). MCT1 protein returns to 
normal levels both proximal and distal to the crush by 7 days, while MCT1 mRNA remains 
reduced throughout the 14 days post-crush. All three major bands shown in Fig. 4A (doublet 
around 48kD and higher band around 60dD) were quantified for this analysis (see Suppl. 
Fig. 1G–I for full Western blots completed for this analysis), since all three bands are 
reduced in MCT1 Het mice (Fig. 1B; Suppl. Fig. 1A) and blocked by antigen peptide pre-
incubation (Suppl. Fig. 1A). It should be noted that MCT1 mRNA or protein in crushed 
nerves is not elevated, compared to uncrushed nerves, at any time point in the first two 
weeks following injury.
MCT1 expression persists in perineurial cells, Schwann cells and DRG neurons following 
peripheral nerve injury
The pattern of cellular expression, evaluated in MCT1 Rep mice and WT mice by MCT1 
immunofluorescence, is unchanged following sciatic nerve crush. Perineurial cells, labeled 
by claudin-1, express MCT1 in uncrushed MCT1 Rep mice (Fig. 5A). Following sciatic 
nerve crush, claudin-1-positive cells, presumed to be perineurial cells, continue to express 
MCT1 despite being internalized within the nerve fascicle (Fig. 5B, C; arrows). In addition 
to labeling in MCT Rep mice, claudin-1 positive perineurial cells in WT mice are also 
immunoreactive for MCT1 (Fig. 5D). As demonstrated previously, MCT1 is also expressed 
in DRG neurons (Fig. 1K, L). There is no qualitative or quantitative change in MCT1 
mRNA expression following nerve crush in DRG, by MCT1 Rep mice (Fig. 5E–G) or real-
time PCR of DRG from WT mice (Fig. 5H) at different time points following sciatic nerve 
crush. The final cell type in the PNS that expresses MCT1 is Schwann cells (Fig. 6). 
Schwann cells labeled by GFP (PLP Rep; green) in sciatic nerve from PLP-GFP transgenic 
mice co-localize with tdTomato from MCT1 Rep mice (red) in uncrushed (Fig. 6A, B) and 1 
week crushed sciatic nerves from double transgenic mice (Fig. 6C, D). MCT1 
immunoreactivity is also seen in Schwann cells, labelled with S100, in uncrushed (Fig. 6E–
H) and 1 week crushed (Fig. 6I, J) sciatic nerves. Though immunoreactive, the intensity of 
MCT1 immunofluorescence in Schwann cells from uncrushed sciatic nerves (Fig. 6F–H; 
arrows) is clearly lower than perineurial cells (arrowheads). MCT1 immunofluorescence 
within Schwann cells appears to be increased following sciatic nerve crush (Fig. 6I, J), but 
this may reflect phagocytosis of MCT1 from other sources (i.e., perineurial cells or 
neurons), rather than true upregulation of MCT1 within Schwann cells. Macrophages and 
terminal Schwann cells are the final two cell-types evaluated, and there is no expression of 
MCT1 by MCT1 Rep mice in either. Macrophages, labelled with MAC2, do not co-localize 
with tdTomato from MCT1 Rep mice in intact or crushed sciatic nerves (Suppl. Fig. 3E–G). 
Additionally, terminal Schwann cells in the muscle, labeled with S100 (Suppl. Fig. 4A–E; 
green), do not co-localize with tdTomato (red) from MCT1 Rep mice in gastrocnemius 
muscles ipsilateral to intact or crushed sciatic nerves (1, 4, 7, or 42 days). Fluorescently-
conjugated bungarotoxin (blue) was used to label the post-synaptic NMJ where the terminal 
Schwann cells are localized. From these experiments, it is clear that MCT1 is expressed in 
perineurial cells, DRG neurons, and Schwann cells in uninjured and crushed sciatic nerves 
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and that the overall level of peripheral nerve expression is initially lowered but rapidly 
returns to baseline after sciatic nerve crush.
The absence of clear upregulation of MCT1 by mRNA or protein in WT mice in one or 
more cell types following nerve injury makes conclusive determination of the exact cell 
types necessary for the function of MCT1 in peripheral nerve regeneration, and the 
mechanism by which MCT1 in these cells support nerve regeneration, more difficult. It does 
not, however, lessen the importance of MCT1 in peripheral nerve regeneration, since only a 
50% decline in MCT1 dramatically delays regeneration. The initial downregulation of 
MCT1 expression suggests that developing therapies to increase MCT1 expression or 
activity could eventually be useful for accelerating peripheral nerve regeneration. In addition 
to being dependent on the speed of axon growth, nerve regeneration also requires robust and 
timely clearance of degenerating axons and myelin after nerve injury. This possible 
mechanism for failed regeneration was further investigated in MCT1 Het mice.
Myelin clearance is transiently disrupted in MCT1 Het mice
Delayed regeneration of peripheral nerves is not necessarily due to slowed axon 
regeneration, but can also be due to impaired clearance of myelin debris (Schafer, Fruttiger 
et al. 1996; Vargas, Watanabe et al. 2010; Farah, Pan et al. 2011; Painter, Brosius Lutz et al. 
2014). As such, myelin clearance was investigated in MCT1 Het mice. Following sciatic 
nerve crush, there is a significant increase in the amount of myelin debris at one week in 
MCT1 Het mice compared to WT mice (Fig. 7A, C, D; arrows), which is cleared by two 
weeks post-crush (Fig. 7A, E, F; arrows). Reduced myelin clearance can be due to either 
attenuated macrophage activity or dysfunctional Schwann cells. To evaluate whether 
macrophages are sufficiently recruited to the injured axon and participate in myelin 
clearance, sciatic nerves from MCT1 Het and WT mice one week following nerve crush 
were immunostained for the macrophage marker, MAC2, and the intensity of 
immunofluorescence quantified by NIH Image J. MAC2 immunoreactivity is unchanged in 
MCT1 Het mice following nerve crush compared to WT mice (Fig. 7B, G–J).
Despite the normal MAC2 immunofluorescence, the increased amount of myelin debris in 
MCT1 Het mice soon after nerve crush suggests a deficiency in the breakdown of injured 
axons and myelin. Though this may contribute to the delay in peripheral nerve regeneration, 
the rapid clearance of myelin debris by 2 weeks post-crush makes it unlikely that this 
process is solely responsible for the delayed nerve regeneration. In addition to macrophages, 
the other cell type that participates in myelin/axon clearance is Schwann cells. In fact, 
Schwann cells have been shown to be the primary phagocytic cell in peripheral nerves 
within the first week after nerve injury (Stoll, Griffin et al. 1989; White, Toews et al. 1989; 
Liu, Yang et al. 1995; Hirata and Kawabuchi 2002). Thus, it is likely that reduced clearance 
of myelin debris in the first week actually reflects a defect in a critical Schwann cell 
function, rather than macrophage function. To investigate this further, we evaluated another 
function of Schwann cells, myelination, to determine if this is also dysfunctional in 
regenerating nerves from MCT1 Het mice.
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Myelination of regenerating peripheral nerve axons is delayed in MCT1 Het mice
In order to evaluate myelination in regenerating peripheral nerves from MCT1 Het mice, 
sural and tibial nerves, which represent distal sensory and mixed (i.e., motor and sensory) 
nerves, respectively, were dissected from MCT1 Het and WT mice at 1–6 weeks following 
sciatic nerve crush. Nerve segments were embedded in resin and processed for toluidine 
blue staining or electron microscopy. Toluidine blue-stained sural nerves from MCT1 Het 
mice, dissected 6 weeks after sciatic nerve crush, have significantly greater g-ratio 
(indicating less myelination) than WT mice (Fig. 8A–C). This is also demonstrated 
electrophysiologically, as the CMAP latency, which reflects the state of myelination, is 
increased in regenerating MCT1 Het nerves following crush, but unchanged without crush 
(Fig. 8D). By electron microscopy, sural nerves isolated from MCT1 Het and WT mice 1 
week following sciatic nerve crush both exhibit degenerating axons, though degenerated 
axons with maintained myelin, which is an earlier stage of myelin clearance, are seen more 
frequently in MCT1 Het mice (Fig. 8E, F). This is also seen in toluidine blue sections of the 
same nerves (Fig. 7C, D). Beginning in WT mice at 2 weeks post-crush, many regenerating 
axons are seen in the sural nerve (Figs. 7D, 8G), while few are seen in MCT1 Het mice at 
this time point (Fig. 7E, 8H). In fact, even at 3 weeks following sciatic nerve crush, sural 
(Fig. 8J) and tibial (Fig. 8L) nerves from MCT1 Het mice continue to have a multitude of 
unmyelinated or thinly myelinated axons, while only fully myelinated axons are seen in 
sural or tibial nerves from WT mice (Fig. 8I, K). Taken together, these results suggest that 
there is a delay in remyelination by Schwann cells in MCT1 Het mice.
Delayed remyelination and phagocytosis, which are both functions of Schwann cells, 
suggest that MCT1 is necessary for Schwann cell function. The exact mechanism by which 
MCT1 contributes to Schwann cell function is not addressed in this publication. Possible 
mechanisms include failure of energy supply to Schwann cells, perhaps through 
dysfunctional perineurial cells, or failure of metabolic energy import into Schwann cells 
through reduced MCT1 in Schwann cells. Future work will aim to distinguish between these 
two possibilities. Schwann cells have high metabolic needs, particularly in the setting of 
axon injury when they are responsible for clearing degenerating axons and myelin, 
providing cues for regrowing axons, and producing myelin components for the regenerating 
axons (Zochodne 2012). Our results suggest that lactate, or other energetic metabolytes 
transported by MCT1, are important for meeting these additional metabolic needs.
Mechanisms for MCT1 in peripheral nerve regeneration
Our results demonstrate that MCT1 expression is important for peripheral nerve 
regeneration following injury. There are several possible mechanisms for this reduced 
regeneration, and our study is not able to definitively distinguish between them. Based on 
the observed localization of MCT1 in the PNS, downregulation of MCT1 in MCT1 Het mice 
could be impacting perineurial cells, Schwann cells or DRG neurons. Of these, MCT1 
expression in perineurial and Schwann cells seem most likely to be responsible. Although 
MCT1 in DRG neurons could be important for nerve regeneration, likely through uptake and 
metabolic utilization of lactate, this mechanism would only explain the delay in nerve 
regeneration of sensory, and not motor, axons. Since regeneration of both are delayed and 
MCT1 is not expressed in motor neurons, as published previously (Lee, Morrison et al. 
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2012) and confirmed in our study by the absence of MCT1 tdTomato reporter in ventral 
roots (Suppl. Fig. 2), perineurial and Schwann cells are more likely the cellular substrate for 
the dependence of nerve regeneration on MCT1.
Perineurial cells are a major component of the blood-nerve barrier (Akert, Sandri et al. 1976; 
Ghabriel, Jennings et al. 1989; Tserentsoodol, Shin et al. 1999; Takebe, Nio-Kobayashi et al. 
2008). In addition to expressing MCT1, they also express glucose transporters (i.e., Glut1)
(Takebe, Nio-Kobayashi et al. 2008). Thus, perineurial cells have all the properties 
necessary to supply the endoneurium with energy metabolites. In this proposed mechanism, 
perineurial cells import glucose from the circulation though Glut1, metabolize it to lactate, 
and then transport lactate into the endoneurium through MCT1 where it may be used as 
metabolic fuel by Schwann cells and axons. This hypothesis is consistent with the growing 
literature that perineurial cells are crucial for developing, as well as recently regenerating, 
peripheral nerves (Kucenas, Takada et al. 2008; Binari, Lewis et al. 2013). Perineurial cells 
may also be important in peripheral neuropathies since they become inflamed and reduce 
their expression of connexins in diabetic rats (Pitre, Seifert et al. 2001), as well as develop 
pathologic changes in human neuropathies (Johnson, Brendel et al. 1981; King, Llewelyn et 
al. 1988; Hill and Williams 2004; Nolte, Hans et al. 2008). Our results provide, for the first 
time, a potential mechanism for this supportive role in developing and regenerating axons—
namely, providing metabolic energy substrates, in the form of lactate, to Schwann cells and 
axons.
Schwann cells, which also express MCT1, are known to be key contributors to axon 
regeneration (Zochodne 2012) and could potentially utilize MCT1 to support peripheral 
nerve regeneration by either importing or exporting lactate. If an importer, intracellular 
lactate may help metabolically support Schwann cell function in normal physiology or repair 
of peripheral nerve injury. If an exporter, lactate produced by Schwann cells may support 
the energy needs of regenerating axons, such as has been demonstrated in the CNS (Lee, 
Morrison et al. 2012).
CONCLUSIONS
In summary, our results demonstrate for the first time that MCT1 expression is important for 
peripheral nerve regeneration following injury. MCT1 is expressed in perineurial cells, 
endoneurial Schwann cells, and DRG neurons, but not in terminal Schwann cells, 
endoneurial macrophages, or sciatic nerve axons. MCT1 Het mice, which express 
approximately 50% of WT MCT1, have delayed regeneration of peripheral nerves following 
sciatic nerve crush. The delay in regeneration occurs in motor nerves, as measured by 
recovery of CMAPs, muscle atrophy, and neuromuscular junction innervation, as well as 
sensory nerves measured by counts of sural nerve axons. Our findings suggest that the delay 
in axonal regeneration is accompanied by a delay or dysfunction of Schwann cells either due 
to reduced availability of endoneurial lactate (secondary to failed transport through the 
perineurium) or decreased uptake of lactate into Schwann cells (secondary to failed import). 
Future studies using cell-specific knockdown of MCT1 by genetic recombination (i.e., 
LoxP) will be exceptionally useful to further dissect the specific role for perineurial, DRG, 
and Schwann cell MCT1.
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Highlights
1. MCT1 expressed in perineurial cells, Schwann cells and dorsal root ganglia 
neurons
2. Uninjured peripheral nerves are normal in MCT1 heterozygous null mice
3. Peripheral nerve regeneration attenuated in MCT1 heterozygous null mice
4. Schwann cells in MCT1 heterozygous null mice dysfunctional during 
regeneration
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Figure 1. Localization of MCT1 in the peripheral nervous system
(A) MCT mRNA expression by real-time RT PCR in the sciatic nerves of wild-type (WT) 
and MCT1 heterozygous null (MCT1 Het) mice. All values are percentages relative to 
MCT1 mRNA in WT mice (n=3). Western blot (B) and densitometry quantification (C) of 
MCT1 protein in WT and MCT1 Het mice. MCT1 immunoreactivity (MCT1 IR) in cross-
section (D) and longitudinal section (E) of sciatic nerve from WT mice alone or co-localized 
with Schwann cell marker, S100 (J). Perineurium (D–I; arrowheads) is strongly 
immunoreactive, though there is some co-localization with Schwann cells (J; arrows) in 
mouse peripheral nerves, as well (D, E scale bars 100 μm; F scale bar 20μm). Identical to 
immunofluorescence, MCT1 BAC tdTomato reporter expression localizes primarily to the 
perineurium (F). Perineurial cells, labelled with claudin-1 immunofluorescence (green), also 
express tdTomato in MCT1 BAC reporter mice (G–I; red, scale bars 5 μm). Dorsal root 
ganglion (DRG) neurons are immunoreactive for MCT1 (K) and positive for MCT1 BAC 
reporter (L; scale bars 50μm). Error bars reflect standard error of the means (S.E.M.).
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Figure 2. Morphology and electrophysiologic properties of nerves from MCT1 Heterozygous null 
(MCT1 Het) mice
Quantification of axon number (A) and axon diameter (B) in sural nerve from WT (n=6) and 
MCT1 Het (n=4) mice. Compound motor action potential (CMAP) amplitude (C) and 
conduction velocity (D) following sciatic nerve stimulation in WT (n=8) and MCT1 Het 
(n=7) mice. Perineurium in WT (E) and MCT1 Het (F) mice (scale bars 1 μm). 
Photomicrographs of wild type (G–I) and MCT1 Het (J–L) sural nerves processed for light 
(G, H, J, K; scale bars 100 μm G, J; 10 μm H, K) and electron (I, L; scale bars 2 μm) 
microscopy. Arrows indicate Remak bundles of unmyelinated axons in WT (I) and MCT1 
Het (L) mice. All error bars reflect S.E.M.
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Figure 3. MCT1 heterozygous null (MCT1 Het) mice have delayed regeneration following sciatic 
nerve injury
(A) Time to recovery of compound motor action potentials (CMAPs) following sciatic nerve 
crush in MCT1 Het (HET; n=9) compared to WT (WT; n=10) mice (Kaplan-Meier curve). 
(B) Mean CMAP amplitude of WT and Het mice pre-crush (time 0) and then from 2 to 5.5 
weeks following sciatic nerve crush (n=10 each). If no CMAP amplitude was recordable, the 
value is counted as 0. Myelinated axon number in the sural nerve (C), which is a pure 
sensory nerve, and tibial nerve (D), which is a mixed motor and sensory nerve, displayed as 
percentage of axon number in uncrushed nerves, at less than 2 weeks (1 and 2 weeks 
combined; n=6 WT, n=5 Het), 3 weeks (n=2 WT, n=2 Het), 4 weeks (n=3 WT, n=3 Het), 
and 6 weeks (n=5 WT, n=5 Het) post-sciatic nerve crush. Sural nerve 4 weeks following 
sciatic nerve crush in WT (E) and Het (F) mice (scale bars 10 μm). Quantification of 
gastrocnemius muscle weights (G; n=12 WT, n=10 Het) and NMJ innervation (H; n=4 WT, 
n=5 Het) in non-denervated and 6 weeks denervated WT and MCT1 Het mice. 
Photomicrographs of hematoxylin and eosin (I–L; scale bars 100 μm) and NMJ (M–P; scale 
bars 20 μm) stained gastrocnemius muscles from non-denervated (Non-Den) WT (I, M) and 
MCT1 Het (J, N) mice or 6 weeks following denervation (Den) in WT (K, O) and MCT1 
Het (L, P) mice. For NMJ staining, presynaptic terminal labeled with synapsin (green) and 
post-synaptic motor endplate labeled with tetrarhodamine-conjugated bungarotoxin (red). 
All error bars reflect S.E.M. * p<0.05, ** p<0.01, *** p<0.001
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Figure 4. MCT1 mRNA and protein quantification following sciatic nerve crush
Western blot (A) and densitometry (B) for MCT1, relative to β-actin reference protein, in 
sciatic nerves that are uncrushed (n=15) or 3 (n=6), 7 (n=6), or 14 (n=6) days following 
crush (both proximal and distal to crush site) from WT mice. Both the lower doublet and 
upper band were quantified for densitometry. MCT1 mRNA (C), by real-time RT PCR 
relative to PPIA reference gene, in sciatic nerves that are uncrushed (n=12) or 3, 7, or 14 
days (n=4 each) following crush (proximal to crush, crush zone, or distal to crush) in WT 
mice. All graphs are shown as percentage of uncrushed. * p<0.05, ** p<0.01, *** p<0.001, 
relative to uncrushed nerves and controlled for multiple comparisons. All error bars reflect 
S.E.M.
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Figure 5. MCT1 expression in perineurial cells of intact and injured sciatic nerves
Uncrushed (A), 1 (B) and 6 (C) weeks post-crush sciatic nerves from MCT1 BAC tdTomato 
reporter (red) immunolabeled with the perineurial cell marker, claudin-1 (green; indicated 
by arrows). Uncrushed sciatic nerves from WT mice (D) immunostained for MCT1 
(MCT1ir; red) and Claudin-1 (green; Scale bars 20 μm). DRG ipsilateral to uncrushed (E), 1 
(F) and 2 (G) weeks crushed sciatic nerves from tdTomato MCT1 reporter mice (red) 
immunostained for non-phosphorylated neurofilament (green; scale bars E–G 50 μm). 
MCT1 mRNA quantification (H), by real-time RT PCR, of DRG following sciatic nerve 
crush (n=9 uncrushed, n=3 for each time point post-crush). All error bars reflect S.E.M.
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Figure 6. MCT1 is expressed by Schwann cells in intact and crushed peripheral nerves
Cross-section of uncrushed (A, B) and 1 week crushed (C, D) sciatic nerves from MCT1 
tdTomato and PLP-GFP double reporter transgenic mice (Scale bars A, C 50 μm; scale bars 
B, D 20 μm). Schwann cells expressing MCT1 (arrows) are indicated by co-localization of 
MCT1 reporter (MCT1 Rep; red) with PLP reporter (PLP Rep; green). Perineurium is 
indicated by arrowheads. Red fluorescence in MCT1 tdTomato reporter mice reflects 
mRNA gene expression within a given cell, but not specific transporter localization within 
the cell (i.e., dendrite versus axon or cell body). Uncrushed sciatic nerve from WT mice 
immunostained with MCT1 (red) and S100 (green) displayed in cross-section (E, F) and 
longitudinal (G, H) photomicrographs (Scale bar E 100 μm; scale bar F–J 20 μm). Sciatic 
nerves 1 week following crush (I, J) immunostained for MCT1 (red) and S100 (green). 
MCT1-immunreactive profiles that co-localize with S100 (i.e., Schwann cells) are indicated 
by arrows and perineurium by arrowheads.
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Figure 7. Myelin debris and macrophage infiltration in MCT1 heterozygous null (MCT1 Het) 
mice following sciatic nerve injury
The number of myelin debris per sural nerve fascicle (A) in WT and MCT1 Het mice are 
quantified at 1 and 2 weeks following sciatic nerve crush (n=4 at 1 week and n=2 at 2 weeks 
for each genotype). Mean MAC2 fluorescent intensity (B) in distal sciatic nerve from WT 
and MCT1 Het mice 1 week following sciatic nerve crush (N=4 of each genotype). Sural 
nerves from wild-type (WT; C, E) and MCT1 Het (D, F) mice 1 (C, D) or 2 (E, F) weeks 
following sciatic nerve crush (scale bars 20 μm). Myelin debris is indicated by arrows and 
newly regenerated axons by arrowheads. Photomicrographs of MAC2 immunofluorescence 
in distal sciatic nerves 1 week following nerve crush in WT (G, H) and MCT1 Het (I, J) 
mice. All error bars reflect S.E.M. * p<0.05, ns non-significant
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Figure 8. Regenerated peripheral nerves in MCT1 Het mice have delayed and incomplete re-
myelination
Uncrushed sural nerves from wild-type (WT; n=475 axons) and MCT1 Het (Het; n=964 
axons) mice have identical G-ratios (A, C), while 6 week regenerated sural nerves from Het 
mice (n=770 axons) have significantly increased G-ratios compared to regenerated WT 
nerves (B, C; n=430 axons), reflecting thinner myelination. Electrophysiologically (D), the 
compound motor action potential (CMAP) latency from regenerating sciatic nerves from Het 
mice, but not uncrushed nerves, are prolonged compared to WT mice, reflecting reduced 
remyelination. Electron photomicrographs of sural nerves 1 weeks post-crush from WT (E) 
and Het (F) mice; 2 weeks post-crush from WT (G) and Het (H) mice; and 3 weeks post-
crush from WT (I) and Het (J) mice, as well as from tibial nerves 3 weeks post-crush from 
WT (K) and Het (L) mice. An early myelin remnant is present in sural nerve from Het mice 
1 week following sciatic nerve crush (F). Thinly myelinated or unmyelinated large axons 
(arrowheads) are seen in both sural (J) and tibial (L) nerves from MCT1 Het, but not WT (I, 
K), mice 3 weeks post-crush. Scale bars are all 2 μm. All error bars reflect S.E.M. * p<0.05, 
ns non-significant
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